Vir Biotechnology, Inc. (VIR)

Vir Biotechnology Statistics

Total Valuation

VIR has a market cap or net worth of $682.90 million. The enterprise value is -$22.67 million.

Market Cap	682.90M
Enterprise Value	-22.67M

Important Dates

The last earnings date was Wednesday, May 7, 2025, after market close.

Earnings Date	May 7, 2025
Ex-Dividend Date	n/a

Share Statistics

VIR has 138.24 million shares outstanding. The number of shares has increased by 1.66% in one year.

Current Share Class	138.24M
Shares Outstanding	138.24M
Shares Change (YoY)	+1.66%
Shares Change (QoQ)	+0.48%
Owned by Insiders (%)	4.38%
Owned by Institutions (%)	55.57%
Float	93.97M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	32.39
Forward PS	31.78
PB Ratio	0.65
P/TBV Ratio	0.67
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 6.79, with a Debt / Equity ratio of 0.09.

Current Ratio	6.79
Quick Ratio	5.88
Debt / Equity	0.09
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -44.59% and return on invested capital (ROIC) is -25.97%.

Return on Equity (ROE)	-44.59%
Return on Assets (ROA)	-23.52%
Return on Invested Capital (ROIC)	-25.97%
Return on Capital Employed (ROCE)	-49.85%
Revenue Per Employee	$51,130
Profits Per Employee	-$1.42M
Employee Count	408
Asset Turnover	0.01
Inventory Turnover	n/a

Taxes

Income Tax	-1.41M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -51.09% in the last 52 weeks. The beta is 1.36, so VIR's price volatility has been higher than the market average.

Beta (5Y)	1.36
52-Week Price Change	-51.09%
50-Day Moving Average	5.65
200-Day Moving Average	7.70
Relative Strength Index (RSI)	45.02
Average Volume (20 Days)	1,616,015

Short Selling Information

The latest short interest is 10.94 million, so 7.92% of the outstanding shares have been sold short.

Short Interest	10.94M
Short Previous Month	10.31M
Short % of Shares Out	7.92%
Short % of Float	11.64%
Short Ratio (days to cover)	8.62

Income Statement

In the last 12 months, VIR had revenue of $20.86 million and -$577.65 million in losses. Loss per share was -$4.22.

Revenue	20.86M
Gross Profit	-476.87M
Operating Income	-583.52M
Pretax Income	-492.27M
Net Income	-577.65M
EBITDA	-570.61M
EBIT	-583.52M
Loss Per Share	-$4.22

Balance Sheet

The company has $801.66 million in cash and $96.10 million in debt, giving a net cash position of $705.57 million or $5.10 per share.

Cash & Cash Equivalents	801.66M
Total Debt	96.10M
Net Cash	705.57M
Net Cash Per Share	$5.10
Equity (Book Value)	1.04B
Book Value Per Share	7.56
Working Capital	794.92M

Cash Flow

In the last 12 months, operating cash flow was -$415.08 million and capital expenditures -$7.06 million, giving a free cash flow of -$422.14 million.

Operating Cash Flow	-415.08M
Capital Expenditures	-7.06M
Free Cash Flow	-422.14M
FCF Per Share	-$3.05

Margins

Gross Margin	n/a
Operating Margin	-2,797.18%
Pretax Margin	-2,775.77%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

VIR does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1.66%
Shareholder Yield	-1.66%
Earnings Yield	-84.59%
FCF Yield	-61.82%

Analyst Forecast

The average price target for VIR is $32.86, which is 565.18% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$32.86
Price Target Difference	565.18%
Analyst Consensus	Strong Buy
Analyst Count	7
Revenue Growth Forecast (5Y)	58.91%
EPS Growth Forecast (5Y)	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

VIR has an Altman Z-Score of 1.05 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.05
Piotroski F-Score	1